Adma Biologics (ADMA) Tax Rate (2011 - 2025)

Adma Biologics (ADMA) reported Tax Rate of 19.83% for Q4 2025, up 24218.0% on a YoY basis from N/an in Q4 2024, and down 15.0% quarter-over-quarter from 23.33% in Q3 2025.

Adma Biologics (ADMA) Tax Rate (2011 - 2025) Analysis & Trends

Adma Biologics has reported Tax Rate for 4 years, with the latest figure at 19.83% in Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate rose 24218.0% year-over-year to 19.83%; the trailing twelve-month figure through Dec 2025 stood at 19.56% (up 7680.0% YoY), and the FY2025 full-year result was 19.56%, up 7680.0% from the prior year.
  • Tax Rate for Q4 2025 stood at 19.83%, down from 23.33% in the prior quarter.
  • The five-year high for Tax Rate was 23.33% in Q3 2025, with the low at 222.35% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -57.14
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -6.79
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 5.61
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 17.68
9 Abivax 91.96 Bn 91.96 Bn - -
10 Adma Biologics 1.98 Bn 1.89 Bn 88.82 Mn 19.83

Historic Data

Download Data
DateValue
Dec 31, 2025 19.83%
Dec 31, 2025 19.83%
Sep 30, 2025 23.33%
Sep 30, 2025 23.33%
Jun 30, 2025 14.66%
Jun 30, 2025 14.66%
Mar 31, 2025 19.57%
Mar 31, 2025 19.57%
Dec 31, 2024 -222.35%
Dec 31, 2024 -222.35%
Sep 30, 2024 2.29%
Sep 30, 2024 2.29%
Jun 30, 2024 10.57%
Jun 30, 2024 10.57%
Mar 31, 2024 3.23%
Mar 31, 2024 3.23%
Mar 31, 2012 50.84%
Mar 31, 2012 50.84%
Mar 31, 2011 16.87%
Mar 31, 2011 16.87%